The paper is available in early access. The study demonstrates AI's potential in detecting micropatterns that may be missed during standard screening. This is an important step towards validating algorithms as "second opinion" tools in clinical oncology.
Source: Scientific Reports
ScienceMedTechOncologyDeep LearningResearch